These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 29898114)

  • 1. Olfactory deficit as a result of clozapine withdrawal syndrome in an animal model of schizophrenia: preliminary results.
    Pacheco FD; Silva MLD; Batista G; Santos W; Castro AA; Canever L; Zugno AI
    An Acad Bras Cienc; 2018; 90(2):1659-1663. PubMed ID: 29898114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosis.
    Chatterjee M; Ganguly S; Srivastava M; Palit G
    Behav Brain Res; 2011 Jan; 216(1):247-54. PubMed ID: 20699106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine.
    Ribeiro BM; do Carmo MR; Freire RS; Rocha NF; Borella VC; de Menezes AT; Monte AS; Gomes PX; de Sousa FC; Vale ML; de Lucena DF; Gama CS; Macêdo D
    Schizophr Res; 2013 Dec; 151(1-3):12-9. PubMed ID: 24257517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and proteomic analyses of neonatal polyI:C-treated adult mice.
    Kitagawa K; Nagai T; Yamada K
    Neurosci Res; 2019 Oct; 147():39-47. PubMed ID: 31446906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia.
    Piontkewitz Y; Assaf Y; Weiner I
    Biol Psychiatry; 2009 Dec; 66(11):1038-46. PubMed ID: 19726031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia.
    Chindo BA; Adzu B; Yahaya TA; Gamaniel KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):310-6. PubMed ID: 22561603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment.
    Nagai T; Kitahara Y; Ibi D; Nabeshima T; Sawa A; Yamada K
    Behav Brain Res; 2011 Nov; 225(1):305-10. PubMed ID: 21835207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole-induced adverse metabolic alterations in polyI:C neurodevelopmental model of schizophrenia in rats.
    Horska K; Ruda-Kucerova J; Drazanova E; Karpisek M; Demlova R; Kasparek T; Kotolova H
    Neuropharmacology; 2017 Sep; 123():148-158. PubMed ID: 28595931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.
    Meltzer HY; Lee MA; Ranjan R; Mason EA; Cola PA
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):176-87. PubMed ID: 8935814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [No rebound psychosis in a case of switching from clozapine to quetiapine].
    Walther S; Baciu D
    Psychiatr Prax; 2006 Mar; 33(2):93-4. PubMed ID: 16502388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clozapine and risperidone antipsychotic drugs on the expression of CACNA1C and behavioral changes in rat 'Ketamine model of schizophrenia.
    Azimi Sanavi M; Ghazvini H; Zargari M; Ghalehnoei H; Hosseini-Khah Z
    Neurosci Lett; 2022 Jan; 770():136354. PubMed ID: 34801642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
    Becker A; Grecksch G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1267-77. PubMed ID: 15588753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats.
    Yang SY; Hong CJ; Huang YH; Tsai SJ
    Neurosci Lett; 2010 Jan; 469(1):127-30. PubMed ID: 19944746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
    Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
    Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine-withdrawal catatonia.
    Wadekar M; Syed S
    Psychosomatics; 2010; 51(4):355-355.e2. PubMed ID: 20587767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawal.
    Poyurovsky M; Bergman Y; Shoshani D; Schneidman M; Weizman A
    Clin Neuropharmacol; 1998; 21(2):97-100. PubMed ID: 9579295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
    Russig H; Murphy CA; Feldon J
    Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia.
    Levin ED; Christopher NC
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):223-9. PubMed ID: 16356617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.